{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:38:54Z","timestamp":1790800734395,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"ANR","award":["ANR-11-IDEX-0005-02"],"award-info":[{"award-number":["ANR-11-IDEX-0005-02"]}]},{"name":"Research on Intractable Disease from the Ministry of Health","award":["JP21gm0010006"],"award-info":[{"award-number":["JP21gm0010006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00281-021-00878-5","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T02:02:33Z","timestamp":1625623353000},"page":"639-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Are there animal models of IgA nephropathy?"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-5646","authenticated-orcid":false,"given":"Renato C.","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"878_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ndt\/4.11.943","volume":"4","author":"R Waldherr","year":"1989","unstructured":"Waldherr R, Rambausek M, Duncker WD, Ritz E (1989) Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4:943\u2013946","journal-title":"Nephrol Dial Transplant"},{"key":"878_CR2","first-page":"813","volume":"36","author":"T Suganuma","year":"1994","unstructured":"Suganuma T (1994) Glomerular IgA deposits in an autopsy study. Nihon Jinzo Gakkai Shi 36:813\u2013822","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"878_CR3","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","volume":"63","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63:2286\u20132294","journal-title":"Kidney Int"},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.150.5.1161","volume":"150","author":"A Rifai","year":"1979","unstructured":"Rifai A, Small PA, Teague PO, Ayoub EM (1979) Experimental IgA nephropathy. J Exp Med 150:1161\u20131173","journal-title":"J Exp Med"},{"key":"878_CR5","first-page":"363","volume":"60","author":"A Rifai","year":"1985","unstructured":"Rifai A, Millard K (1985) Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol 60:363\u2013368","journal-title":"Clin Exp Immunol"},{"key":"878_CR6","first-page":"216","volume":"130","author":"A Chen","year":"1988","unstructured":"Chen A, Wong SS, Rifai A (1988) Glomerular immune deposits in experimental IgA nephropathy: a continuum of circulating and in situ formed immune complexes. Am J Pathol 130:216\u2013222","journal-title":"Am J Pathol"},{"key":"878_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0090-1229(81)90152-5","volume":"20","author":"K Isaacs","year":"1981","unstructured":"Isaacs K, Miller F, Lane B (1981) Experimental model for IgA nephropathy. Clin Immunol Immunopathol 20:419\u2013426","journal-title":"Clin Immunol Immunopathol"},{"key":"878_CR8","first-page":"198","volume":"47","author":"K Isaacs","year":"1982","unstructured":"Isaacs K, Miller F (1982) Role of antigen size and charge in immune complex glomerulonephritis. I. Active induction of disease with dextran and its derivatives. Lab Investig 47:198\u2013205","journal-title":"Lab Investig"},{"key":"878_CR9","first-page":"70","volume":"157","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Tomino Y (2007) The mucosa-bone-marrow axis in IgA nephropathy. Contrib Nephrol 157:70\u201379","journal-title":"Contrib Nephrol"},{"key":"878_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1084\/jem.157.2.572","volume":"157","author":"SN Emancipator","year":"1983","unstructured":"Emancipator SN, Gallo GR, Lamm ME (1983) Experimental IgA nephropathy induced by oral immunization. J Exp Med 157:572\u2013582","journal-title":"J Exp Med"},{"key":"878_CR11","first-page":"72","volume":"26","author":"R Coppo","year":"1986","unstructured":"Coppo R, Basolo B, Rollino C, Roccatello D, Martina G, Amore A, Bongiorno G, Piccoli G (1986) Mediterranean diet and primary IgA nephropathy. Clin Nephrol 26:72\u201382","journal-title":"Clin Nephrol"},{"key":"878_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0140-6736(88)92913-3","volume":"2","author":"V Kumar","year":"1988","unstructured":"Kumar V, Sieniawska M, Beutner EH, Chorzelski TP (1988) Are immunological markers of gluten-sensitive enteropathy detectable in IgA nephropathy? Lancet 2:1307","journal-title":"Lancet"},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bmj.295.6590.78","volume":"295","author":"A Fornasieri","year":"1987","unstructured":"Fornasieri A, Sinico RA, Maldifassi P, Bernasconi P, Vegni M, D\u2019Amico G (1987) IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 295:78\u201380","journal-title":"Br Med J"},{"key":"878_CR14","doi-asserted-by":"crossref","unstructured":"Rostoker G, Laurent J, Andr\u00e9 C, Cholin S, Lagrue G (1988) High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet 356-357","DOI":"10.1016\/S0140-6736(88)91147-6"},{"key":"878_CR15","first-page":"499","volume":"60","author":"R Coppo","year":"1989","unstructured":"Coppo R, Mazzucco G, Martina G, Roccatello D, Amore A, Novara R, Bargoni A, Piccoli G, Sena LM (1989) Gluten-induced experimental IgA glomerulopathy. Lab Investig 60:499\u2013506","journal-title":"Lab Investig"},{"key":"878_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0278-6915(98)00072-6","volume":"36","author":"D Yan","year":"1998","unstructured":"Yan D, Rumbeiha WK, Pestka JJ (1998) Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies. Food Chem Toxicol 36:1095\u20131106","journal-title":"Food Chem Toxicol"},{"key":"878_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0378-4274(03)00024-9","volume":"140-141","author":"JJ Pestka","year":"2003","unstructured":"Pestka JJ (2003) Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett 140-141:287\u2013295","journal-title":"Toxicol Lett"},{"key":"878_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jnutbio.2005.12.002","volume":"17","author":"Y Shi","year":"2006","unstructured":"Shi Y, Pestka JJ (2006) Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression. J Nutr Biochem 17:697\u2013706","journal-title":"J Nutr Biochem"},{"key":"878_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000189643","volume":"75","author":"F Hinoshita","year":"1997","unstructured":"Hinoshita F, Suzuki Y, Yokoyama K, Hara S, Yamada A, Ogura Y, Hashimoto H, Tomura S, Marumo F, Ueno Y (1997) Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol. Nephron 75:469\u2013478","journal-title":"Nephron"},{"key":"878_CR20","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.145.11.3684","volume":"145","author":"L Gesualdo","year":"1990","unstructured":"Gesualdo L, Lamm ME, Emancipator SN (1990) Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684\u20133691","journal-title":"J Immunol"},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","volume":"21","author":"RC Monteiro","year":"2003","unstructured":"Monteiro RC, Van De Winkel JGJ (2003) IgA Fc receptors. Annu Rev Immunol 21:177\u2013204","journal-title":"Annu Rev Immunol"},{"key":"878_CR22","first-page":"474","volume":"71","author":"ME Diebel","year":"2011","unstructured":"Diebel ME, Diebel LN, Liberati DM (2011) Gender dimorphism in the gut: mucosal protection by estrogen stimulation of IgA transcytosis. J Trauma 71:474\u2013479","journal-title":"J Trauma"},{"key":"878_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ki.1995.25","volume":"47","author":"A Koyama","year":"1995","unstructured":"Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, Irie F, Goto M, Igarashi M, Iitsuka T, Aoki Y, Sakurai H, Sakurayama N, Fukao K (1995) Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int 47:207\u2013216","journal-title":"Kidney Int"},{"key":"878_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2215\/CJN.01030306","volume":"1","author":"AA Satoskar","year":"2006","unstructured":"Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L (2006) Nadasdy T:Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 1:1179\u20131186","journal-title":"Clin J Am Soc Nephrol"},{"key":"878_CR25","first-page":"504","volume":"17","author":"S Sharmin","year":"2004","unstructured":"Sharmin S, Shimizu Y, Hagiwara M, Hirayama K, Koyama A (2004) Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb\/c mice. J Nephrol 17:504\u2013511","journal-title":"J Nephrol"},{"key":"878_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0140-6736(94)90875-3","volume":"343","author":"S Suzuki","year":"1994","unstructured":"Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M (1994) Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 343:12\u201316","journal-title":"Lancet"},{"key":"878_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000049068","volume":"90","author":"C Yamamoto","year":"2002","unstructured":"Yamamoto C, Suzuki S, Kimura H, Yoshida H, Gejyo F (2002) Experimental nephropathy induced by Haemophilus parainfluenzae antigens. Nephron 90:320\u2013327","journal-title":"Nephron"},{"key":"878_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0065-2776(08)60046-2","volume":"29","author":"DD Porter","year":"1980","unstructured":"Porter DD, Larsen AE, Porter HG (1980) Aleutian disease of mink. Adv Immunol 29:261\u2013286","journal-title":"Adv Immunol"},{"key":"878_CR29","first-page":"227","volume":"96","author":"JL Portis","year":"1979","unstructured":"Portis JL, Coe JE (1979) Deposition of IgA in renal glomeruli of mink affected with Aleutian disease. Am J Pathol 96:227\u2013236","journal-title":"Am J Pathol"},{"key":"878_CR30","first-page":"379","volume":"67","author":"RH Jessen","year":"1992","unstructured":"Jessen RH, Emancipator SN, Jacobs GH (1992) Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status. Lab Investig 67:379\u2013386","journal-title":"Lab Investig"},{"key":"878_CR31","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ki.1985.76","volume":"27","author":"H Imai","year":"1985","unstructured":"Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura A (1985) Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27:756\u2013761","journal-title":"Kidney Int"},{"key":"878_CR32","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/ki.1996.517","volume":"50","author":"E Muso","year":"1996","unstructured":"Muso E, Yoshida H, Takeuchi E, Yashiro M, Matsushima H, Oyama A, Suyama K, Kawamura T, Kamata T, Miyawaki S, Izui S, Sasayama S (1996) Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int 50:1946\u20131957","journal-title":"Kidney Int"},{"key":"878_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1681\/ASN.2004030219","volume":"16","author":"H Suzuki","year":"2005","unstructured":"Suzuki H, Suzuki Y, Yamanaka T, Hirose S, Nishimura H, Toei J, Horikoshi S, Tomino Y (2005) Genome-wide association study in IgA nephropathy model identifies susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 16:1289\u20131299","journal-title":"J Am Soc Nephrol"},{"key":"878_CR34","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1681\/ASN.2011121160","volume":"23","author":"K Okazaki","year":"2012","unstructured":"Okazaki K, Suzuki Y, Otsuji M, Suzuki H, Kihara M, Kajiyama T, Hashimoto A, Nishimura H, Brown R, Hall S, Novak J, Izui S, Hirose S, Tomino Y (2012) Establishment of a novel ddY mouse model with early onset IgA nephropathy. J Am Soc Nephrol 23:1364\u20131374","journal-title":"J Am Soc Nephrol"},{"key":"878_CR35","first-page":"141","volume":"10","author":"AW van den Wall Bake","year":"1989","unstructured":"van den Wall Bake AW, Daha MR, van Es LA (1989) Immunopathogenetic aspects of IgA nephropathy. Nephrologie 10:141\u2013145","journal-title":"Nephrologie"},{"key":"878_CR36","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.1996.396","volume":"50","author":"JW de Fijter","year":"1996","unstructured":"de Fijter JW, Eijgenraam JW, Braam CA, Holmgren J, Daha MR, van Es LA, van den Wall Bake AW (1996) Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50:952\u2013961","journal-title":"Kidney Int"},{"key":"878_CR37","first-page":"64","volume":"72","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Suzuki H, Sato D, Kajiyama T, Okazaki K, Hashimoto A, Kihara M, Yamaji K, Satake K, Nakata J, Aizawa M, Novak J, Tomino Y (2011) Reevaluation of the mucosa-bone marrow axis in IgA nephropathy with animal models. Adv Otorhinolaryngol 72:64\u201367","journal-title":"Adv Otorhinolaryngol"},{"key":"878_CR38","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/ASN.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19:2384\u20132395","journal-title":"J Am Soc Nephrol"},{"key":"878_CR39","doi-asserted-by":"publisher","first-page":"819646","DOI":"10.1155\/2011\/819646","volume":"2011","author":"T Kajiyama","year":"2011","unstructured":"Kajiyama T, Suzuki Y, Kihara M, Suzuki H, Horikoshi S, Tomino Y (2011) Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy. Clin Dev Immunol 2011:819646","journal-title":"Clin Dev Immunol"},{"key":"878_CR40","doi-asserted-by":"crossref","unstructured":"Kano T, Suzuki H, Makita Y, Fukao Y, Suzuki Y (in press) Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy. Kidney Int 2021","DOI":"10.1016\/j.kint.2021.04.026"},{"key":"878_CR41","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ndt\/gfr403","volume":"27","author":"D Sato","year":"2012","unstructured":"Sato D, Suzuki Y, Kano T, Suzuki H, Matsuoka J, Yokoi H, Horikoshi S, Ikeda K, Tomino Y (2012) Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients. Nephrol Dial Transplant 27:1090\u20131097","journal-title":"Nephrol Dial Transplant"},{"key":"878_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4772","volume":"2","author":"K Hirano","year":"2019","unstructured":"Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y (2019) Association between tonsillectomy and outcomes in patients with immunoglobulin A nephropathy. JAMA Netw Open 2:e194772","journal-title":"JAMA Netw Open"},{"key":"878_CR43","doi-asserted-by":"publisher","first-page":"e89707","DOI":"10.1371\/journal.pone.0089707","volume":"9","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Nakata J, Suzuki H, Sato D, Kano T, Yanagawa H, Matsuzaki K, Horikoshi S, Novak J, Tomino Y (2014) Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One 9:e89707","journal-title":"PLoS One"},{"key":"878_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ki.5002300","volume":"72","author":"H Suzuki","year":"2007","unstructured":"Suzuki H, Suzuki Y, Aizawa M, Yamanaka T, Kihara M, Pang H, Horikoshi S, Tomino Y (2007) Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int 72:319\u2013327","journal-title":"Kidney Int"},{"key":"878_CR45","doi-asserted-by":"publisher","first-page":"e95365","DOI":"10.1371\/journal.pone.0095365","volume":"9","author":"M Aizawa","year":"2014","unstructured":"Aizawa M, Suzuki Y, Suzuki H, Pang H, Kihara M, Nakata J, Yamaji K, Horikoshi S, Tomino Y (2014) Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy. PLoS One 9:e95365","journal-title":"PLoS One"},{"key":"878_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/ndt\/gfs467","volume":"28","author":"J Nakata","year":"2013","unstructured":"Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Horikoshi S, Novak J, Tomino Y (2013) Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs. Nephrol Dial Transplant 28:320\u2013326","journal-title":"Nephrol Dial Transplant"},{"key":"878_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP (2011) Genome-wide association study identifies dusceptibility loci for IgA nephropathy. Nat Genet 43:321\u2013327","journal-title":"Nat Genet"},{"key":"878_CR48","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerov\u00e1 D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, P\u0105czek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG (2014) Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 46:1187\u20131196","journal-title":"Nat Genet"},{"key":"878_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.1047","volume":"44","author":"XQ Yu","year":"2011","unstructured":"Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, Li Y, Foo JN, Wang W, Li ZJ, Yin XY, Tang XQ, Fan L, Chen J, Li RS, Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ (2011) A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44:178\u2013182","journal-title":"Nat Genet"},{"key":"878_CR50","doi-asserted-by":"publisher","first-page":"e0137044","DOI":"10.1371\/journal.pone.0137044","volume":"10","author":"YG Kim","year":"2015","unstructured":"Kim YG, Alvarez M, Suzuki H, Hirose S, Izui S, Tomino Y, Bertrand H, Suzuki Y (2015) Pathogenic role of a proliferation-inducing ligand (APRIL) in murine IgA nephropathy. PLoS One 10:e0137044","journal-title":"PLoS One"},{"key":"878_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.kint.2019.01.031","volume":"96","author":"JR Myette","year":"2019","unstructured":"Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG (2019) A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy. Kidney Int 96:104\u2013116","journal-title":"Kidney Int"},{"key":"878_CR52","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1681\/ASN.2016050496","volume":"28","author":"M Muto","year":"2017","unstructured":"Muto M, Manfroi B, Suzuki H, Joh K, Nagai M, Wakui S, Righini C, Maiguma M, Izui S, Tomino Y, Huard B, Suzuki Y (2017) Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cell in IgA nephropathy. J Am Soc Nephrol 28:1227\u20131238","journal-title":"J Am Soc Nephrol"},{"key":"878_CR53","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","volume":"97","author":"Y Makita","year":"2020","unstructured":"Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y (2020) TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy. Kidney Int 97:340\u2013349","journal-title":"Kidney Int"},{"key":"878_CR54","first-page":"1668","volume":"119","author":"H Suzuki","year":"2009","unstructured":"Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119:1668\u20131677","journal-title":"J Clin Invest"},{"key":"878_CR55","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10157-013-0921-6","volume":"18","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Matsuzaki K, Suzuki H, Okazaki K, Yanagawa H, Ieiri N, Sato M, Sato T, Taguma Y, Matsuoka J, Horikoshi S, Novak J, Hotta O, Tomino Y (2014) Serum levels of galactose deficient IgA1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol 18:770\u2013777","journal-title":"Clin Exp Nephrol"},{"key":"878_CR56","doi-asserted-by":"publisher","first-page":"e98081","DOI":"10.1371\/journal.pone.0098081","volume":"9","author":"H Yanagawa","year":"2014","unstructured":"Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y (2014) A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PLoS One 9:e98081","journal-title":"PLoS One"},{"key":"878_CR57","doi-asserted-by":"publisher","first-page":"e0190967","DOI":"10.1371\/journal.pone.0190967","volume":"13","author":"WJ Placzek","year":"2018","unstructured":"Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H (2018) Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. PLoS One 13:e0190967","journal-title":"PLoS One"},{"key":"878_CR58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/IJNRD.S50513","volume":"7","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Suzuki H, Makita Y, Takahata A, Takahashi K, Muto M, Sasaki Y, Kelimu A, Matsuzaki K, Yanagawa H, Okazaki K, Tomino Y (2014) Diagnosis and activity assessment of IgA nephropathy: current perspectives on non-invasive testing with aberrantly glycosylated IgA-related biomarkers. Int J Nephrol Renov Dis 7:409\u2013414","journal-title":"Int J Nephrol Renov Dis"},{"key":"878_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm.4012","volume":"22","author":"S Arai","year":"2016","unstructured":"Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y, Sugisawa R, Matsumoto A, Mori M, Yoshihara Y, Doi K, Maehara N, Kusunoki S, Takahata A, Noiri E, Suzuki Y, Yahagi N, Nishiyama A, Gunaratnam L, Takano T, Miyazaki T (2016) AIM\/CD5L enhances intraluminal debris clearance and ameliorates acute kidney injury. Nat Med 22:183\u2013193","journal-title":"Nat Med"},{"key":"878_CR60","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1681\/ASN.2019100987","volume":"31","author":"A Takahata","year":"2020","unstructured":"Takahata A, Arai S, Hiramoto E, Kitada K, Kato R, Makita Y, Suzuki H, Nakata J, Araki K, Miyazaki T, Suzuki Y (2020) Crucial role of AIM\/CD5L in the development of glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 31:2013\u20132024","journal-title":"J Am Soc Nephrol"},{"key":"878_CR61","doi-asserted-by":"publisher","first-page":"35251","DOI":"10.1038\/srep35251","volume":"6","author":"R Sugisawa","year":"2016","unstructured":"Sugisawa R, Hiramoto E, Matsuoka S, Iwai S, Takai R, Yamazaki T, Mori N, Okada Y, Takeda N, Yamamura K, Arai T, Arai S, Miyazaki T (2016) Impact of feline AIM on the susceptibility of cats to renal disease. Sci Rep 6:35251","journal-title":"Sci Rep"},{"issue":"9","key":"878_CR62","first-page":"694","volume":"74","author":"J Berger","year":"1968","unstructured":"Berger J, Hinglais N (1968) Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris) 74(9):694\u2013695","journal-title":"J Urol Nephrol (Paris)"},{"issue":"10","key":"878_CR63","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00251-003-0626-1","volume":"55","author":"T Maruoka","year":"2004","unstructured":"Maruoka T, Nagata T, Kasahara M (2004) Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics. 55(10):712\u2013716","journal-title":"Immunogenetics."},{"issue":"12","key":"878_CR64","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1182\/blood.V93.12.4387","volume":"93","author":"M van Egmond","year":"1999","unstructured":"van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L, Hofhuis FM, Saito T, Mayadas TN, Verbeek JS, van de Winkel JG (1999) Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b\/CD18). Blood. 93(12):4387\u20134394","journal-title":"Blood."},{"key":"878_CR65","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","volume":"191","author":"P Launay","year":"2000","unstructured":"Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC (2000) Fca receptor (CD89) mediates the development of Immunoglobulin A (IgA) nephropathy (Berger\u2019s Disease): evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 191:1999\u20132009","journal-title":"J Exp Med"},{"issue":"4","key":"878_CR66","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","volume":"209","author":"L Berthelot","year":"2012","unstructured":"Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PHM, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogn\u00e9 M, Moura IC, Monteiro RC (2012) Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209(4):793\u2013806","journal-title":"J Exp Med"},{"key":"878_CR67","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/eji.200636826","volume":"37","author":"Y Kanamaru","year":"2007","unstructured":"Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC (2007) Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Eur J Immunol 37:1116\u20131128","journal-title":"Eur J Immunol"},{"issue":"7","key":"878_CR68","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1073\/pnas.0912393107","volume":"107","author":"S Duchez","year":"2010","unstructured":"Duchez S, Amin R, Cogn\u00e9 N, Delpy L, Sirac C, Pascal V, Corth\u00e9sy B, Cogn\u00e9 M (2010) Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci U S A 107(7):3064\u20133069. https:\/\/doi.org\/10.1073\/pnas.0912393107 Epub 2010 Jan 28","journal-title":"Proc Natl Acad Sci U S A"},{"key":"878_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.194.4.417","volume":"194","author":"IC Moura","year":"2001","unstructured":"Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC (2001) Identification of the transferrin receptor as a novel immunoglobulin A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 194:417\u2013425","journal-title":"J Exp Med"},{"key":"878_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/01.ASN.0000046961.04917.83","volume":"14","author":"E Haddad","year":"2003","unstructured":"Haddad E, Moura IC, Arcos-Fajardo M, Macher M-A, Baudouin V, Alberti C, Loirat C, Monteiro RC, Peuchmaur M (2003) Enhanced expression of the CD71 mesangial IgA1 receptor in Berger\u2019s disease and Henoch-Sch\u00f6nlein nephritis : association between CD71 expression and IgA deposits. J Am Soc Nephrol 14:327\u2013337","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"878_CR71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/j.gastro.2012.05.051","volume":"143","author":"C Lebreton","year":"2012","unstructured":"Lebreton C, M\u00e9nard S, Abed J, Moura IC, Coppo R, Dugave C, Monteiro RC, Fricot A, Traore MG, Griffin M, Cellier C, Malamut G, Cerf-Bensussan N, Heyman M (2012) Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology. 143(3):698\u2013707","journal-title":"Gastroenterology."},{"issue":"9","key":"878_CR72","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1681\/ASN.2015080911","volume":"27","author":"Z Oruc","year":"2016","unstructured":"Oruc Z, Oblet C, Boumediene A, Druilhe A, Pascal V, Le Rumeur E, Cuvillier A, El Hamel C, Lecardeur S, Leanderson T, Morelle W, Demengeot J, Aldigier JC, Cogn\u00e9 M (2016) IgA structure variations associate with immune stimulations and IgA mesangial deposition. J Am Soc Nephrol 27(9):2748\u20132761. https:\/\/doi.org\/10.1681\/ASN.2015080911 Epub 2016 Jan 29","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"878_CR73","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2018111089","volume":"30","author":"B Wehbi","year":"2019","unstructured":"Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogn\u00e9 E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogn\u00e9 M, Aldigier JC (2019) Mesangial deposition can strongly involve innate-like IgA molecules lacking affinity maturation. J Am Soc Nephrol 30(7):1238\u20131249. https:\/\/doi.org\/10.1681\/ASN.2018111089 Epub 2019 Jun 21","journal-title":"J Am Soc Nephrol"},{"issue":"10 Suppl","key":"878_CR74","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1681\/ASN.V210s173","volume":"2","author":"R Coppo","year":"1992","unstructured":"Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2(10 Suppl):S173\u2013S180","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"878_CR75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ki.2015.94","volume":"88","author":"C Papista","year":"2015","unstructured":"Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC (2015) Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Kidney Int 88(2):276\u2013285. https:\/\/doi.org\/10.1038\/ki.2015.94 Epub 2015 Mar 25","journal-title":"Kidney Int"},{"issue":"9","key":"878_CR76","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1681\/ASN.2015080856","volume":"27","author":"SM Lechner","year":"2016","unstructured":"Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L (2016) IgA1 protease treatment reverses mesangial deposits and hematuria in a model of IgA nephropathy. J Am Soc Nephrol 27(9):2622\u20132629. https:\/\/doi.org\/10.1681\/ASN.2015080856","journal-title":"J Am Soc Nephrol"},{"key":"878_CR77","doi-asserted-by":"crossref","unstructured":"Segelmark M, Uhlin F, Sonesson E on behalf of the GOOD-IDES-01 study team. The immunoglobulin G degrading enzyme imlifidase for the treatment of anti-GBM disease \u2013 the GOOD-IDES-01 trial. Poster session at ASN in 2020","DOI":"10.1681\/ASN.20203110S1B9b"},{"issue":"10084","key":"878_CR78","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/S0140-6736(17)30550-0","volume":"389","author":"BC Fellstr\u00f6m","year":"2017","unstructured":"Fellstr\u00f6m BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, S\u00f8rensen SS, Tesar V, Del Vecchio L (2017) NEFIGAN Trial Investigators. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 389(10084):2117\u20132127. https:\/\/doi.org\/10.1016\/S0140-6736(17)30550-0 Epub 2017 Mar","journal-title":"Lancet."},{"key":"878_CR79","doi-asserted-by":"publisher","first-page":"e99006","DOI":"10.1371\/journal.pone.0099006","volume":"9","author":"M De Angelis","year":"2014","unstructured":"De Angelis M, Montemurno E, Piccolo M, Vannini L, Lauriero G, Maranzano V, Gozzi G, Serrazanetti D, Dalfino G, Gobbetti M et al (2014) Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One 9:e99006. https:\/\/doi.org\/10.1371\/journal.pone.0099006","journal-title":"PLoS One"},{"issue":"7","key":"878_CR80","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/ndt\/gfy323","volume":"34","author":"JM Chemouny","year":"2019","unstructured":"Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, Monot C, Bredel M, Bex-Coudrat J, Sannier A, Daugas E, Vrtovsnik F, Gesualdo L, Leclerc M, Berthelot L, Ben Mkaddem S, Lepage P, Monteiro RC (2019) Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice. Nephrol Dial Transplant 34(7):1135\u20131144. https:\/\/doi.org\/10.1093\/ndt\/gfy323","journal-title":"Nephrol Dial Transplant"},{"key":"878_CR81","unstructured":"Lauriero G, Abbad L, Vacca M, Calasso M, Chemouny J, Berthelot L, Gesualdo L, De Angelis M, Monteiro RC. Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of IgA Nephropathy (article in revision)"},{"key":"878_CR82","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/jpm11040309","volume":"11","author":"V Di Leo","year":"2021","unstructured":"Di Leo V, Gleeson PJ, Sallustio F, Bounaix C, Da Silva J, Loreto G, Mkaddem SB, Monteiro RC (2021) Rifaximin as a potential treatment for IgA nephropathy in a humanized mice model. J Pers Med 11:309","journal-title":"J Pers Med"},{"issue":"9","key":"878_CR83","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/12458","volume":"5","author":"F Zheng","year":"1999","unstructured":"Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB (1999) Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 5(9):1018\u20131025. https:\/\/doi.org\/10.1038\/12458","journal-title":"Nat Med"},{"issue":"3","key":"878_CR84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/ajkd.2002.34890","volume":"40","author":"R Coppo","year":"2002","unstructured":"Coppo R, Chiesa M, Cirina P, Peruzzi L, Amore A, European IgACE Study Group (2002) In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am J Kidney Dis 40(3):495\u2013503","journal-title":"Am J Kidney Dis"},{"key":"878_CR85","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1172\/JCI20096","volume":"113","author":"J Wang","year":"2004","unstructured":"Wang J, Anders RA, Wu Q, Peng D, Cho JH, Sun Y, Karaliukas R, Kang HS, Turner JR, Fu YX (2004) Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest 113:826\u2013835","journal-title":"J Clin Invest"},{"issue":"11","key":"878_CR86","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.4049\/jimmunol.172.11.7177","volume":"172","author":"R Marquina","year":"2004","unstructured":"Marquina R, D\u00edez MA, L\u00f3pez-Hoyos M, Buelta L, Kuroki A, Kikuchi S et al (2004) Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL\/6)F(1)-bcl-2 transgenic mice. J Immunol 172(11):7177\u20137185","journal-title":"J Immunol"},{"key":"878_CR87","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1172\/JCI45563","volume":"121","author":"DD McCarthy","year":"2011","unstructured":"McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MAE, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL (2011) Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 121:3991\u20134002","journal-title":"J Clin Invest"},{"issue":"2","key":"878_CR88","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2353\/ajpath.2007.060559","volume":"170","author":"T Nishie","year":"2007","unstructured":"Nishie T, Miyaishi O, Azuma H, Kameyama A, Naruse C, Hashimoto N, Yokoyama H, Narimatsu H, Wada T, Asano M (2007) Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol f\u00e9vr 170(2):447\u2013456","journal-title":"Am J Pathol f\u00e9vr"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-021-00878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00281-021-00878-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-021-00878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:56:12Z","timestamp":1725371772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00281-021-00878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1007\/s00281-021-00878-5","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments with a1KICD89Tg mice were performed in accordance with the French Council of Animal Care guidelines and national ethical guidelines of Paris-Nord Animal Care Committee (Comit\u00e9 d\u2019\u00c9thique Exp\u00e9rimentation Animale Bichat-Debr\u00e9). The experimental protocol gddY mice for gd was approved by the Ethics Review Committee for Animal Experimentation of Juntendo University Faculty of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not needed for animal studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Some studies with gddY mice were in collaboration with Kyowa-Kirin Co ltd., Visterra Inc. Some studies of \u03b11KICD89Tg mice were funded by Shire Co.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}